Health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial.
Insurer won't pay for breast cancer drug
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.